Article
Fatal Non-Hepatic Hyperammonemia Post-Glofitamab: Ureaplasma and Genetic Susceptibility: A Case Report.
Immunity, inflammation and disease - 1 Apr 2026
Wu Yinshan, Guo Xiuliu, Wang Xiaoling, Guo Feng
Abstract excerpt
BACKGROUND: Although primarily reported in solid organ transplant recipients and patients undergoing chimeric antigen receptor T-cell immunotherapy (CAR-T), non-hepatic hyperammonemia (NHHA) is a rare but lethal complication in the broader context of post- chemo-immunotherapy hematologic malignancies. It often presents with unexplained encephalopathy that mimics primary central nervous system (CNS) progression,...
Topics
Join the communities discussing this publication.